Recent Faculty Publications
Our neurological research frequently appears in leading academic journals and reflects a broad scope of interests.
- Sweadner KJ, Arystarkhova E, Haq IU, Brashear A, Ozelius LJ. (2025) Pathogenic Variants in A TP1A3: Why Is There So Much Confusion?. Neurology. Genetics (Dec), 11(6): e200320.
- Mirmosayyeb O, Balconi J, Santivasci C, Dong X, Young N, Szigeti K, Benedict RHB. (2025) Predictive role of Neuroticism and Conscientiousness in conversion from mild cognitive impairment to Alzheimer's disease. Aging & mental health (Dec)1-8.
- Feinstein A, Bar-Or A, Benedict RHB, Filippi M, Freedman DE, Kever A, Meza C, Rocca MA. (2025) Is multiple sclerosis-related depression different from depression in general? The data for and against. Brain : a journal of neurology (Dec), 148(12): 4210-4221.
- Balconi J, Jaworski M, Mirmosayyeb O, Woodbeck M, Weinstock Z, Zak N, Cruz S, Dong X, Camarata S, Santivasci C, Bergsland N, Weinstock-Guttman B, Dwyer MG, Zivadinov R, Covey TJ, Benedict RHB. (2025) Auditory test of processing speed: Further validation and test-retest reliability. Multiple sclerosis and related disorders (Nov), 105: 106867.
- Wicks TR, Wolska A, Ghazal D, Jakimovski D, Weinstock-Guttman B, Burnham A, Bergsland N, Dwyer MG, Remaley AT, Zivadinov R, Ramanathan M. (2025) Frailty Exacerbates Disability in Progressive Multiple Sclerosis. Annals of clinical and translational neurology (Nov).
- Abrams AW, Waltz M, Casper TC, Aaen G, Benson LA, Bernfeld EM, Charvet LE, Chitnis T, Francisco C, Gorman MP, Graves JS, Krupp L, O'Neill K, Lotze TE, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Rutatangwa A, Schreiner T, Shukla N, Tillema JM, Weinstock-Guttman B, Wheeler Y, Waubant E, Krysko KM, . (2025) Real-World Effectiveness of Switching to Oral or Infusion Versus Injectable Disease-Modifying Therapy in Pediatric Multiple Sclerosis. Annals of neurology (Nov).
- Barohn RJ, Wolfe GI, Saperstein DS, Dimachkie MM. (2025) Pattern Recognition Approach to Neuropathy and Neuronopathy. Neurologic clinics (Nov), 43(4): 617-635.
- Ruzhansky K, Li Y, Wolfe GI, Muppidi S, Guptill JT, Hehir MK, Dimachkie MM, Kaminski HJ, Howard JF, Narayanaswami P. (2025) Letter to the Editor. Reply to the Letter to the Editor: The Role of Patient-Reported Symptoms in Standardizing MGFA Class 0 and MGFA-PIS. Muscle & nerve (Nov), 72(5): 1186-1187.
- Balconi J, Jaworski M, Mirmosayyeb O, Woodbeck M, Weinstock Z, Zak N, Cruz S, Dong X, Camarata S, Santivasci C, Bergsland N, Weinstock-Guttman B, Dwyer MG, Zivadinov R, Covey TJ, Benedict RHB. (2025) Auditory test of processing speed: Further validation and test-retest reliability. Multiple sclerosis and related disorders (Nov), 105: 106867.
- Ranpariya M, Qutab N, Hanson J, Li P, Foster H, Farooq O. (2025) Prevalence and Functional Significance of 14 and 6 Hz Positive Spikes in Self-Limited Epilepsy With Centrotemporal Spikes: A Case-Control Study. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society (Oct).
- Foong YC, Merlo D, Gresle M, Buzzard K, Horakova D, Havrdova EK, Kalincik T, Roos I, Hodgkinson S, Lechner-Scott J, Lugaresi A, Weinstock-Guttman B, Ozakbas S, Surcinelli A, Foschi M, Boz C, Khoury SJ, Yamout B, Laureys G, Blanco Y, Skibina O, Kuhle J, John N, Alroughani R, Prevost J, Van Pesch V, Tomassini V, Prat A, Girard M, Terzi M, Shaygannejad V, Ampapa R, Gray O, Etemadifar M, Guimarães J, McCombe PA, Gerlach O, Solaro C, Butzkueven H, Zhu C, van der Walt A, Study Group M. (2025) Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry (Oct).
- O'Neill KA, Charvet L, Waltz M, George A, Benson LA, Gorman MP, Mar SS, Ness JM, Schreiner T, Waubant E, Weinstock-Guttman B, Wheeler YS, Abrams AW, Chitnis T, Rodriguez M, Rose JW, Tillema JM, Virupakshaiah A, Casper TC, Krupp LB, . (2025) Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years. Neurology (Oct), 105(8): e214142.
- Goyal N, Qi C, Stone J, Ruck T, Wolfe GI, Smith AG, Gelinas D, Jefferson M, Brauer E, Suthagar TB, Menon RR, Sato M, Phillips G, Narayanaswami P. (2025) Reduction in oral glucocorticoid use after efgartigimod initiation in clinical practice among patients with generalized myasthenia gravis. Journal of the neurological sciences (Oct), 477: 123652.
- Nauman H, Wells GE, Iosipchuk O, Rafizadeh C, Truax B, Wender C, Picone MA, Pandey K, Benedict RHB, Cutter GR, Motl RW, Sandroff BM. (2025) Safety, adherence, and compliance in a RCT of supervised exercise training among persons with multiple sclerosis who have slowed cognitive processing speed. Multiple sclerosis and related disorders (Oct), 102: 106713.
- Haq IU, Simonyan K, Napoli E, Ozelius LJ, Snively BM, Whitlow CT, Sweadner KJ, Brashear A. (2025) Structural Alterations in the Gray Matter Volume in Rapid-Onset Dystonia-Parkinsonism. Movement disorders : official journal of the Movement Disorder Society (Sep).
- Nyarady H, Tripoli M, Shucard DW, O'Donnell R, Haller M, Benedict RHB, Weinstock-Guttman B, Towers SM, Covey TJ. (2025) Neurophysiological indices of distinct cognitive operations during symbol digit modalities test performance in multiple sclerosis: a pilot study. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology (Sep), 182: 2111376.
- Hu C, Son J, McAlpine L, Walker ELS, Dahl M, Song E, Ferreira Brito S, Kavak K, Onomichi K, Bar-Or A, Perrone C, Riley CS, Weinstock-Guttman B, De Jager PL, Longbrake EE, Xia Z. (2025) Long COVID in People With Multiple Sclerosis and Related Disorders: A Multicenter Cross-Sectional Study. Annals of clinical and translational neurology (Sep).
- Zivadinov R, Weinstock-Guttman B. (2025) Letter to the Editor. Exploring the natural age cutoff point for primary-progressive multiple sclerosis therapy. Expert review of neurotherapeutics (Sep), 25(9): 1007-1009.
- Fuchs TA, Ziccardi S, Jelgerhuis JR, Killestein J, Strijbis EMM, Zivadinov R, Weinstock-Guttman B, Schoonheim MM, Calabrese M. (2025) Verona validation of the DAAE score, a tool for estimating risk of clinical disease progression in people with multiple sclerosis. Multiple sclerosis and related disorders (Sep), 101: 106586.
- Nyarady H, Tripoli M, Shucard DW, O'Donnell R, Haller M, Benedict RHB, Weinstock-Guttman B, Towers SM, Covey TJ. (2025) Neurophysiological indices of distinct cognitive operations during symbol digit modalities test performance in multiple sclerosis: a pilot study. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology (Sep), 182: 2111376.
Director's Welcome
Choosing the Right Neurology Residency
Upcoming Events
No events scheduled.